- Home
- MRNA vs MTZ Comparison
MRNA vs MTZ Comparison
Compare MRNA & MTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- MTZ
- Stock Information
- Founded
- MRNA 2010
- MTZ 1929
- Country
- MRNA United States
- MTZ United States
- Employees
- MRNA N/A
- MTZ N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- MTZ Water Sewer Pipeline Comm & Power Line Construction
- Sector
- MRNA Health Care
- MTZ Industrials
- Exchange
- MRNA Nasdaq
- MTZ Nasdaq
- Market Cap
- MRNA 10.6B
- MTZ 12.3B
- IPO Year
- MRNA 2018
- MTZ N/A
- Fundamental
- Price
- MRNA $27.26
- MTZ $154.97
- Analyst Decision
- MRNA Hold
- MTZ Strong Buy
- Analyst Count
- MRNA 19
- MTZ 17
- Target Price
- MRNA $48.13
- MTZ $162.69
- AVG Volume (30 Days)
- MRNA 14.2M
- MTZ 908.6K
- Earning Date
- MRNA 05-01-2025
- MTZ 05-01-2025
- Dividend Yield
- MRNA N/A
- MTZ N/A
- EPS Growth
- MRNA N/A
- MTZ N/A
- EPS
- MRNA N/A
- MTZ 2.70
- Revenue
- MRNA $3,177,000,000.00
- MTZ $12,464,333,000.00
- Revenue This Year
- MRNA N/A
- MTZ $12.32
- Revenue Next Year
- MRNA $8.98
- MTZ $8.79
- P/E Ratio
- MRNA N/A
- MTZ $57.66
- Revenue Growth
- MRNA N/A
- MTZ 3.03
- 52 Week Low
- MRNA $23.15
- MTZ $89.96
- 52 Week High
- MRNA $158.82
- MTZ $166.95
- Technical
- Relative Strength Index (RSI)
- MRNA 50.60
- MTZ 66.65
- Support Level
- MRNA $25.22
- MTZ $145.46
- Resistance Level
- MRNA $27.15
- MTZ $157.38
- Average True Range (ATR)
- MRNA 1.61
- MTZ 4.42
- MACD
- MRNA 0.26
- MTZ -0.89
- Stochastic Oscillator
- MRNA 47.66
- MTZ 65.37
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About MTZ MasTec Inc.
MasTec is a leading infrastructure construction company operating mainly in North America across a range of industries. The company's primary activities include engineering, building, installing, maintaining, and upgrading communications, oil and gas, utility, renewable energy, and other infrastructure. MasTec reports its results under five segments: communications; clean energy and infrastructure; oil and gas; power delivery; and other.